
Avanos Medical AVNS
€ 11.77
0.0%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Avanos Medical Kurzfristige Verbindlichkeiten 2011-2026 | AVNS
Kurzfristige Verbindlichkeiten Jährlich Avanos Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 165 M | 166 M | 235 M | 186 M | 139 M | 166 M | 212 M | 264 M | 390 M | 324 M | 315 M | 356 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 390 M | 139 M | 243 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
219 M | $ 11.75 | - | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
11 M | $ 8.98 | - | $ 322 M | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 18.41 | - | $ 121 M | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.01 | - | $ 1.22 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 1.35 | - | $ 21.8 M | ||
|
Inogen
INGN
|
63.5 M | $ 6.32 | - | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
10.2 M | $ 100.97 | - | $ 1.28 B | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
LivaNova PLC
LIVN
|
808 M | $ 62.4 | - | $ 3.4 B | ||
|
LENSAR
LNSR
|
15 M | $ 5.56 | - | $ 64 M | ||
|
AxoGen
AXGN
|
23.6 M | $ 32.61 | - | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
315 M | $ 36.56 | - | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
12.9 B | $ 86.58 | - | $ 111 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
10.5 M | $ 24.7 | - | $ 209 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.7 | - | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
1.9 M | $ 2.16 | - | $ 3.37 M | ||
|
InspireMD
NSPR
|
10.7 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
170 M | $ 11.72 | - | $ 464 M | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 11.48 | - | $ 1.55 B | ||
|
Myomo
MYO
|
8.35 M | $ 0.7 | - | $ 29.3 M | ||
|
Penumbra
PEN
|
183 M | $ 334.17 | - | $ 13 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.4 | - | $ 141 M | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.91 | - | $ 146 M | ||
|
Insulet Corporation
PODD
|
680 M | $ 225.5 | - | $ 15.9 B | ||
|
Quanterix Corporation
QTRX
|
74.8 M | $ 3.82 | - | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 15.91 | - | $ 373 M |